Results 161 to 170 of about 15,652 (174)

The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)

FEBS Letters, 1998
Angela CLERK, Peter H Sugden
exaly  

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

European Journal of Pharmaceutical Sciences, 2001
Sona Hudecová, Albert Breier, M Barancik   +2 more
exaly  

SB203580 Induces Prolonged B-Raf Activation and Promotes Neuronal Differentiation upon EGF Treatment of PC12 Cells

Biochemistry (Moscow), 2004
Rony Seger, Eui-Ju Choi, Young Sook Yoo   +2 more
exaly  

SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus

Neuroscience Letters, 2000
John J O’Connor
exaly  

SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes

European Journal of Pharmacology, 2008
Radim Vrzal, Barbora Papoušková, Petr Bednar   +2 more
exaly  

Selectivity of SB203580, SB202190 and Other Commonly Used p38 Inhibitors: Profiling Against a Multi-Enzyme Panel

Letters in Drug Design & Discovery, 2005
Jacqueline Norris, Kevin Williams, William Janzen, C. Hodge, Leonard Blackwell, Ioana Popa-Burke   +5 more
openaire   +1 more source

Ginnalin A and SB203580 show additive effect on Hep-3B hepatocellular carcinoma cell line

Turkish Journal of Biochemistry, 2019
Hasibe Vural
exaly  

Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult

Journal of Neuroscience Research, 2003
Jung-Bin Kim, Pyung-Lim Han, Ja-Kyeong Lee   +2 more
exaly  

The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway

British Journal of Pharmacology, 2000
Albertus T J Wierenga, Wiebe Kruijer, Edo Vellenga   +2 more
exaly  

Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells

Leukemia Research, 2001
Yuki Ishii, Shingo Sakai, Yoshio Honma   +2 more
exaly